Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessing and Addressing Social Determinants of HIV among Female Sex Workers in the Dominican Republic and Tanzania through Community Empowerment-Based Responses.
Kerrigan D, Donastorg Y, Barrington C, Perez M, Gomez H, Mbwambo J, Likindikoki S, Mantsios A, Beckham SW, Leddy A, Karver TS, Galai N, Davis WW. Kerrigan D, et al. Among authors: mantsios a. Curr HIV/AIDS Rep. 2020 Apr;17(2):88-96. doi: 10.1007/s11904-020-00485-3. Curr HIV/AIDS Rep. 2020. PMID: 32072467 Free PMC article. Review.
Project Shikamana: Baseline Findings From a Community Empowerment-Based Combination HIV Prevention Trial Among Female Sex Workers in Iringa, Tanzania.
Kerrigan D, Mbwambo J, Likindikoki S, Beckham S, Mwampashi A, Shembilu C, Mantsios A, Leddy A, Davis W, Galai N. Kerrigan D, et al. Among authors: mantsios a. J Acquir Immune Defic Syndr. 2017 Jan 1;74 Suppl 1(Suppl 1):S60-S68. doi: 10.1097/QAI.0000000000001203. J Acquir Immune Defic Syndr. 2017. PMID: 27930613 Free PMC article. Clinical Trial.
Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States.
Kerrigan D, Mantsios A, Grant R, Markowitz M, Defechereux P, La Mar M, Beckham SW, Hammond P, Margolis D, Murray M. Kerrigan D, et al. Among authors: mantsios a. AIDS Behav. 2018 Nov;22(11):3540-3549. doi: 10.1007/s10461-017-2017-x. AIDS Behav. 2018. PMID: 29290075 Free PMC article.
Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain.
Kerrigan D, Mantsios A, Gorgolas M, Montes ML, Pulido F, Brinson C, deVente J, Richmond GJ, Beckham SW, Hammond P, Margolis D, Murray M. Kerrigan D, et al. Among authors: mantsios a. PLoS One. 2018 Jan 5;13(1):e0190487. doi: 10.1371/journal.pone.0190487. eCollection 2018. PLoS One. 2018. PMID: 29304154 Free PMC article. Clinical Trial.
Essential elements of a community empowerment approach to HIV prevention among female sex workers engaged in project Shikamana in Iringa, Tanzania.
Leddy AM, Mantsios A, Davis W, Muraleetharan O, Shembilu C, Mwampashi A, Beckham SW, Galai N, Likindikoki S, Mbwambo J, Kerrigan D. Leddy AM, et al. Among authors: mantsios a. Cult Health Sex. 2020 Apr;22(sup1):111-126. doi: 10.1080/13691058.2019.1659999. Epub 2019 Sep 9. Cult Health Sex. 2020. PMID: 31496423 Free PMC article. Clinical Trial.
Project Shikamana: Community Empowerment-Based Combination HIV Prevention Significantly Impacts HIV Incidence and Care Continuum Outcomes Among Female Sex Workers in Iringa, Tanzania.
Kerrigan D, Mbwambo J, Likindikoki S, Davis W, Mantsios A, Beckham SW, Leddy A, Shembilu C, Mwampashi A, Aboud S, Galai N. Kerrigan D, et al. Among authors: mantsios a. J Acquir Immune Defic Syndr. 2019 Oct 1;82(2):141-148. doi: 10.1097/QAI.0000000000002123. J Acquir Immune Defic Syndr. 2019. PMID: 31513552 Free PMC article. Clinical Trial.
"It made me more confident that I have it under control": Patient and provider perspectives on moving to a two-drug ART regimen in the United States and Spain.
Davis W, Mantsios A, Karver T, Murray M, Punekar Y, Ward D, Bredeek UF, Moreno S, Merino D, Knobel H, Campis A, Kerrigan D. Davis W, et al. Among authors: mantsios a. PLoS One. 2020 May 1;15(5):e0232473. doi: 10.1371/journal.pone.0232473. eCollection 2020. PLoS One. 2020. PMID: 32357195 Free PMC article.
Efficacy and Freedom: Patient Experiences with the Transition from Daily Oral to Long-Acting Injectable Antiretroviral Therapy to Treat HIV in the Context of Phase 3 Trials.
Mantsios A, Murray M, Karver TS, Davis W, Margolis D, Kumar P, Swindells S, Bredeek UF, García Del Toro M, Garcia Gasalla M, Rubio García R, Antela A, Hudson K, Griffith S, Kerrigan D. Mantsios A, et al. AIDS Behav. 2020 Dec;24(12):3473-3481. doi: 10.1007/s10461-020-02918-x. AIDS Behav. 2020. PMID: 32410051 Clinical Trial.
36 results